Jane Street’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-68,500
| Closed | -$1.27M | – | 10060 |
|
|
2023
Q3 | $1.27M | Buy |
68,500
+46,100
| +206% | +$521K | ﹤0.01% | 4802 |
|
|
2023
Q2 | $248K | Sell |
22,400
-25,200
| -53% | -$351K | ﹤0.01% | 7401 |
|
|
2023
Q1 | $639K | Buy |
47,600
+17,900
| +60% | +$310K | ﹤0.01% | 5890 |
|
|
2022
Q4 | $367K | Sell |
29,700
-9,000
| -23% | -$127K | ﹤0.01% | 6664 |
|
|
2022
Q3 | $540K | Sell |
38,700
-5,000
| -11% | -$80.5K | ﹤0.01% | 6557 |
|
|
2022
Q2 | $603K | Sell |
43,700
-11,700
| -21% | -$187K | ﹤0.01% | 6400 |
|
|
2022
Q1 | $901K | Buy |
55,400
+20,100
| +57% | +$315K | ﹤0.01% | 6347 |
|
|
2021
Q4 | $575K | Sell |
35,300
-32,600
| -48% | -$550K | ﹤0.01% | 7002 |
|
|
2021
Q3 | $1.01M | Sell |
67,900
-113,200
| -63% | -$1.81M | ﹤0.01% | 5889 |
|
|
2021
Q2 | $3.62M | Buy |
181,100
+107,700
| +147% | +$2.14M | ﹤0.01% | 3219 |
|
|
2021
Q1 | $1.69M | Sell |
73,400
-57,600
| -44% | -$1.61M | ﹤0.01% | 4349 |
|
|
2020
Q4 | $3.24M | Buy |
131,000
+59,300
| +83% | +$1.97M | ﹤0.01% | 2726 |
|
|
2020
Q3 | $2.97M | Sell |
71,700
-13,800
| -16% | -$634K | ﹤0.01% | 2453 |
|
|
2020
Q2 | $4.1M | Buy |
85,500
+68,100
| +391% | +$5.26M | ﹤0.01% | 2095 |
|
|
2020
Q1 | $1.1M | Sell |
17,400
-9,700
| -36% | -$872K | ﹤0.01% | 2702 |
|
|
2019
Q4 | $3.36M | Buy |
+27,100
| New | +$2.43M | ﹤0.01% | 1416 |
|
|
2019
Q3 | – | Sell |
-10,300
| Closed | -$820K | – | 5941 |
|
|
2019
Q2 | $820K | Sell |
10,300
-7,300
| -41% | -$653K | ﹤0.01% | 2958 |
|
|
2019
Q1 | $1.97M | Buy |
+17,600
| New | +$1.92M | ﹤0.01% | 2044 |
|
|
2018
Q3 | – | Sell |
-3,200
| Closed | -$269K | – | 5864 |
|
|
2018
Q2 | $269K | Sell |
3,200
-4,800
| -60% | -$351K | ﹤0.01% | 4250 |
|
|
2018
Q1 | $492K | Sell |
8,000
-4,700
| -37% | -$283K | ﹤0.01% | 3489 |
|
|
2017
Q4 | $742K | Sell |
12,700
-6,000
| -32% | -$378K | ﹤0.01% | 2717 |
|
|
2017
Q3 | $1.08M | Sell |
18,700
-7,000
| -27% | -$754K | ﹤0.01% | 2209 |
|
|
2017
Q2 | $3.11M | Buy |
+25,700
| New | +$2.98M | 0.01% | 1100 |
|
|
2017
Q1 | – | Sell |
-78,900
| Closed | -$8.57M | – | 4819 |
|
|
2016
Q4 | $8.57M | Buy |
78,900
+71,400
| +952% | +$8.51M | 0.04% | 429 |
|
|
2016
Q3 | $1.23M | Buy |
7,500
+5,500
| +275% | +$867K | 0.01% | 1693 |
|
|
2016
Q2 | $285K | Sell |
2,000
-7,800
| -80% | -$1.14M | ﹤0.01% | 3385 |
|
|
2016
Q1 | $1.26M | Buy |
+9,800
| New | +$1.16M | 0.01% | 1642 |
|
|
2015
Q2 | – | Sell |
-5,200
| Closed | -$1.47M | – | 4160 |
|
|
2015
Q1 | $1.47M | Buy |
+5,200
| New | +$1.13M | 0.01% | 1083 |
|
Jane Street's ICPT Position: Q4 2023 in Review
Jane Street sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 14,201 shares — an estimated $263K sold.
Jane Street first reported a position in ICPT in Q4 2013 and held it in 29 quarters. The position peaked at $5.8M in Q1 2015. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Jane Street reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Jane Street sold 14,201 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $263K.
- Jane Street first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 29 quarters.
- Jane Street's Intercept Pharmaceuticals, Inc. position peaked at $5.8M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.